GCFN could effectively induce lipid peroxidation and ferroptosis in AML cells by reducing the expression levels of intracellular GSH and inhibiting the activity of GPX4, thus providing a basis for GCFN as a potential treatment for AML. This evidence concerns the gene GPX4 and acute myeloid leukemia.